|
| << previous | next >> |
Journal description
All volumes of the corresponding journal
All issues of the corresponding volume
All articles of the corresponding issues
Details for article 18 of 25 found articles
| Title: |
Rationale and design of ApoA-I Event Reducing in Ischemic Syndromes II (AEGIS-II): A phase 3, multicenter, double-blind, randomized, placebo-controlled, parallel-group study to investigate the efficacy and safety of CSL112 in subjects after acute myocardial infarction |
| Author: |
Gibson, C. Michael Kastelein, John J.P. Phillips, Adam T. Aylward, Philip E. Yee, Megan K. Tendera, Michal Nicholls, Stephen J. Pocock, Stuart Goodman, Shaun G. Alexander, John H. Lincoff, A. Michael Bode, Christoph Duffy, Danielle Heise, Mark Berman, Gail Mears, Sojaita Jenny Tricoci, Pierluigi Deckelbaum, Lawrence I. Steg, P. Gabriel Ridker, Paul Mehran, Roxana |
| Appeared in: |
American heart journal |
| Paging: | Volume 231 () nr. C pages 121-127 |
| Year: |
2021 |
| Contents: | |
| Publisher: |
The Authors |
| Source file: |
Elektronische Wetenschappelijke Tijdschriften |
Details for article 18 of 25 found articles
| << previous | next >> |